331 related articles for article (PubMed ID: 31004370)
1. The cost of diabetic foot ulcers and amputations to the National Health Service in England.
Kerr M; Barron E; Chadwick P; Evans T; Kong WM; Rayman G; Sutton-Smith M; Todd G; Young B; Jeffcoate WJ
Diabet Med; 2019 Aug; 36(8):995-1002. PubMed ID: 31004370
[TBL] [Abstract][Full Text] [Related]
2. Cost of diabetic foot disease to the National Health Service in England.
Kerr M; Rayman G; Jeffcoate WJ
Diabet Med; 2014 Dec; 31(12):1498-504. PubMed ID: 24984759
[TBL] [Abstract][Full Text] [Related]
3. Annual Direct Medical Costs of Diabetic Foot Disease in Brazil: A Cost of Illness Study.
Toscano CM; Sugita TH; Rosa MQM; Pedrosa HC; Rosa RDS; Bahia LR
Int J Environ Res Public Health; 2018 Jan; 15(1):. PubMed ID: 29316689
[TBL] [Abstract][Full Text] [Related]
4. Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers.
Hicks CW; Selvarajah S; Mathioudakis N; Perler BA; Freischlag JA; Black JH; Abularrage CJ
J Vasc Surg; 2014 Nov; 60(5):1247-1254.e2. PubMed ID: 24939079
[TBL] [Abstract][Full Text] [Related]
5. Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting.
Apelqvist J; Ragnarson-Tennvall G; Larsson J; Persson U
Foot Ankle Int; 1995 Jul; 16(7):388-94. PubMed ID: 7550950
[TBL] [Abstract][Full Text] [Related]
6. Outcomes and cost minimisation associated with outpatient parenteral antimicrobial therapy (OPAT) for foot infections in people with diabetes.
Malone M; West D; Xuan W; Lau NS; Maley M; Dickson HG
Diabetes Metab Res Rev; 2015 Sep; 31(6):638-45. PubMed ID: 25850572
[TBL] [Abstract][Full Text] [Related]
7. Losing a foot versus losing a dollar; a systematic review of cost studies in diabetic foot complications.
Petrakis I; Kyriopoulos IJ; Ginis A; Athanasakis K
Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):165-180. PubMed ID: 28283002
[TBL] [Abstract][Full Text] [Related]
8. Can the introduction of a 12-lead ECG help reduce mortality in those presenting with foot ulceration to multidisciplinary diabetic foot clinics? An observational evaluation of a real-world implementation pilot in England.
Valabhji J; Holman N; Collins N; Young RJ; Chadwick P; Robinson A; Nayar R; Rajbhandari S; Coppini DV; Kong MF; Ashwell S; Nayak A; Mehta S; Manu C; Edmonds M; Gooday C; Dhatariya K
Diabetologia; 2024 Jul; 67(7):1304-1314. PubMed ID: 38584181
[TBL] [Abstract][Full Text] [Related]
9. The costs of diabetic foot: the economic case for the limb salvage team.
Driver VR; Fabbi M; Lavery LA; Gibbons G
J Vasc Surg; 2010 Sep; 52(3 Suppl):17S-22S. PubMed ID: 20804928
[TBL] [Abstract][Full Text] [Related]
10. Predicted annual costs for inpatients with diabetes and foot ulcers in a developing country-a simulation of the current situation in Brazil.
Rezende KF; Ferraz MB; Malerbi DA; Melo NH; Nunes MP; Pedrosa HC; Chacra AR
Diabet Med; 2010 Jan; 27(1):109-12. PubMed ID: 20121897
[TBL] [Abstract][Full Text] [Related]
11. Geographic variation in Medicare spending and mortality for diabetic patients with foot ulcers and amputations.
Sargen MR; Hoffstad O; Margolis DJ
J Diabetes Complications; 2013; 27(2):128-33. PubMed ID: 23062327
[TBL] [Abstract][Full Text] [Related]
12. Multidisciplinary clinics reduce treatment costs and improve patient outcomes in diabetic foot disease.
Joret MO; Osman K; Dean A; Cao C; van der Werf B; Bhamidipaty V
J Vasc Surg; 2019 Sep; 70(3):806-814. PubMed ID: 30850290
[TBL] [Abstract][Full Text] [Related]
13. Wound healing in diabetes. Outcome and costs.
Apelqvist J
Clin Podiatr Med Surg; 1998 Jan; 15(1):21-39. PubMed ID: 9463766
[TBL] [Abstract][Full Text] [Related]
14. The financial burden of surgical and endovascular treatment of diabetic foot wounds.
Joret MO; Dean A; Cao C; Stewart J; Bhamidipaty V
J Vasc Surg; 2016 Sep; 64(3):648-55. PubMed ID: 27565588
[TBL] [Abstract][Full Text] [Related]
15. What is the most effective way to reduce incidence of amputation in the diabetic foot?
Apelqvist J; Larsson J
Diabetes Metab Res Rev; 2000; 16 Suppl 1():S75-83. PubMed ID: 11054894
[TBL] [Abstract][Full Text] [Related]
16. Burden of Infected Diabetic Foot Ulcers on Hospital Admissions and Costs.
Hicks CW; Selvarajah S; Mathioudakis N; Sherman RE; Hines KF; Black JH; Abularrage CJ
Ann Vasc Surg; 2016 May; 33():149-58. PubMed ID: 26907372
[TBL] [Abstract][Full Text] [Related]
17. Health-economic consequences of diabetic foot lesions.
Ragnarson Tennvall G; Apelqvist J
Clin Infect Dis; 2004 Aug; 39 Suppl 2():S132-9. PubMed ID: 15306992
[TBL] [Abstract][Full Text] [Related]
18. Diabetes-related amputations create considerable public health burden in the UK.
Graz H; D'Souza VK; Alderson DEC; Graz M
Diabetes Res Clin Pract; 2018 Jan; 135():158-165. PubMed ID: 29133201
[TBL] [Abstract][Full Text] [Related]
19. The health care costs of diabetic peripheral neuropathy in the US.
Gordois A; Scuffham P; Shearer A; Oglesby A; Tobian JA
Diabetes Care; 2003 Jun; 26(6):1790-5. PubMed ID: 12766111
[TBL] [Abstract][Full Text] [Related]
20. A model to estimate cost-savings in diabetic foot ulcer prevention efforts.
Barshes NR; Saedi S; Wrobel J; Kougias P; Kundakcioglu OE; Armstrong DG
J Diabetes Complications; 2017 Apr; 31(4):700-707. PubMed ID: 28153676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
